SCHEMBL1408449

SCHEMBL1408449

CC(O)NS(N)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6337087 1.00
SCHEMBL3014273 0.79 CA1 (0.39)
Aniline SCHEMBL2018487 0.79 CA1 (0.44)
SCHEMBL41981 0.75
SCHEMBL3425587 0.73
SCHEMBL4444546 0.73
SCHEMBL19972925 0.73
Hydrochloric Acid SCHEMBL11829521 0.73
SCHEMBL22457464 0.71 CA1 (0.36)
SCHEMBL2396421 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070155933-A1 Liquid polyethercarbonatediol compound and thermoplastic polyurethane obtained therefrom UBE INDUSTRIES, LTD. (JP) 2007-07-05 US claimed
EP-1707586-A1 LIQUID POLYETHER CARBONATE DIOL COMPOUND AND THERMOPLASTIC POLYURETHANE OBTAINED THEREFROM Ube Industries, Ltd. (JP) 2006-10-04 EP claimed
US-12195576-B2 Polyol compositions and methods SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2025-01-14 US disclosed
EP-2838954-B1 ADHESIVE COMPOSITIONS AND METHODS SAUDI ARAMCO TECH CO (SA) 2024-09-18 EP disclosed
EP-4359460-A1 POLYOL COMPOSITIONS AND METHODS SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2024-05-01 EP disclosed
US-11654150-B2 Darunavir combination formulations JANSSEN SCIENCES IRELAND UC (IE) 2023-05-23 US disclosed
US-20230136594-A1 TRICYCLIC P2-LIGAND CONTAINING POTENT HIV-PROTEASE INHIBITORS PURDUE RESEARCH FOUNDATION 2023-05-04 US disclosed
US-20230026948-A1 POLYOL COMPOSITIONS AND METHODS ARAMCO PERFORMANCE MATERIALS LLC 2023-01-26 US disclosed
EP-4121042-A1 TRICYCLIC P2-LIGAND CONTAINING POTENT HIV-PROTEASE INHIBITORS Purdue Research Foundation (US) 2023-01-25 EP disclosed
WO-2022269512-A1 POLYOL COMPOSITIONS AND METHODS SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2022-12-29 WO disclosed
US-20220002469-A1 POLYOL COMPOSITIONS AND METHODS SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2022-01-06 US disclosed
EP-0813542-A1 AMINO ACID HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1997-12-29 EP disclosed
EP-0810209-A2 Alpha - and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
WO-1996028464-A1 BIS-AMINO ACID HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1996-09-19 WO disclosed
WO-1996028418-A1 SULFONYLALKANOYLAMINO HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1996-09-19 WO disclosed
WO-1996028463-A1 AMINO ACID HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1996-09-19 WO disclosed
EP-0715618-A1 HYDROXYETHYLAMINO SULPHONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1996-06-12 EP disclosed
EP-0656887-A1 HYDROXYETHYLAMINO SULFONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1995-06-14 EP disclosed
WO-1995006030-A1 HYDROXYETHYLAMINO SULPHONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1995-03-02 WO disclosed
WO-1994004492-A1 HYDROXYETHYLAMINO SULFONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1994-03-03 WO disclosed